For the Inventor, By the Inventor

Enter inventor name

Chestnut Hill, MA, United States of America

William R Sellers

USPTO Granted Patents = 13

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 6.5

ph-index = 7

Forward Citations = 625(Granted Patents)

Location History:

Brookline, MA (US) (1998 - 2011)
Chestnut Hill, MA (US) (2005 - 2024)

Company Filing History:

13 out of 1,210

Dana-farber-cancer Institute Inc.

The General Hospital Corporation

Whitehead Institute for Biomedical Research

4. 1 out of 1,373

The Brigham and Women's Hospital, Inc.

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

Loading Chart...

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12006555 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2024-06-11),

2. 10669589 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2020-06-02),

3. 10000815 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2018-06-19),

4. 9035036 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2015-05-19),

5. 8465916 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2013-06-18),

6. 8105769 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2012-01-31),

7. 7981609 - Methods for identifying and using SNP panels (2011-07-19),

8. 7964349 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2011-06-21),

9. 7501248 - Prostate cancer diagnosis and outcome prediction by expression analysis (2009-03-10),

10. 7294468 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2007-11-13),

11. 6949342 - Prostate cancer diagnosis and outcome prediction by expression analysis (2005-09-27),

12. 5981723 - Retinoblastoma-associated protein 1 CDNA (1999-11-09),

13. 5759803 - Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and (1998-06-02),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…